Here we set outto develop mouse models of mutant KRAS-driven lung cancer with an elevated tumormutational burden by expressing the human DNA cytosine deaminase, APOBEC3B, tomimic the mutational signature seen in human lung cancer. The gene discussed is KRAS; the disease is lung carcinoma.